The manufacturer of high-tech prosthetics "Motorika" (LLC "MK Homo Auctus", "Motorika" group) increased its revenue by 113% to 4.2 billion rubles in a year. This became known from the company's IFRS reporting.
The company's net profit amounted to 1.7 billion rubles.
The growth in sales of upper and lower limb prostheses was supported by the demand for Russian-made technical rehabilitation equipment both in Russia and the CIS countries, against the backdrop of the departure of some foreign manufacturers from the market.
According to the report, the sale of solutions for upper limb prosthetics accounts for more than 4 billion rubles of revenue. The company manufactures lower limb prostheses, wheelchairs, neurostimulators and other medical devices. The largest contribution to revenue growth was made by sales of bionic prostheses, which work with an external energy source.
"Motorika" actively operates in Russia and the CIS, and also has a subsidiary in India. This allows it to expand its presence in international markets.
At the end of December 2024, the company bought 50.1% of the assets of "Special Equipment Plant" (specializing in the production of wheelchairs. In 2026, the company plans to conduct an IPO (initial public offering of the company's shares on the stock exchange).
Read materials on the topic:
Creators of Russian prostheses "Motorika" will receive 900 million rubles for development
Production of cyber prostheses and implants with intuitive control will be launched in Moscow
No phantom pains: the sensitivity of cyber prostheses has been increased in Vladivostok
